Beijing Science Sun Pharmaceutical Co Ltd (300485) — Net Asset Quality Index
Beijing Science Sun Pharmaceutical Co Ltd (300485) has a Net Asset Quality Index of 95.2% as of September 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥3.60 Billion minus total liabilities of CN¥171.26 Million yields net assets of CN¥3.43 Billion. A higher index indicates a stronger, lower-leverage balance sheet. Check asset resilience ratio of Beijing Science Sun Pharmaceutical Co Lt to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Beijing Science Sun Pharmaceutical Co Ltd Net Asset Quality Index Over Time (2011–2024)
This chart shows how Beijing Science Sun Pharmaceutical Co Ltd's Net Asset Quality Index has evolved across 14 annual periods from 2011 to 2024. As of September 2025, the index stands at 95.2%, representing net assets of CN¥3.43 Billion against total assets of CN¥3.60 Billion CNY. See working capital to net assets of Beijing Science Sun Pharmaceutical Co Lt to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for Beijing Science Sun Pharmaceutical Co Ltd (2011–2024)
The table below presents the year-by-year Net Asset Quality Index for Beijing Science Sun Pharmaceutical Co Ltd from 2011 to 2024, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see 300485 market cap overview.
| Year | Quality Index | Net Assets (CNY) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 95.3% | CN¥3.39 Billion | CN¥3.55 Billion | CN¥166.48 Million | ▼ -0.4 pp |
| 2023 | 95.7% | CN¥3.47 Billion | CN¥3.62 Billion | CN¥154.61 Million | ▲ +0.1 pp |
| 2022 | 95.6% | CN¥3.41 Billion | CN¥3.57 Billion | CN¥157.10 Million | ▼ -0.9 pp |
| 2021 | 96.5% | CN¥3.28 Billion | CN¥3.40 Billion | CN¥118.54 Million | ▲ +1.2 pp |
| 2020 | 95.3% | CN¥2.85 Billion | CN¥2.99 Billion | CN¥141.13 Million | ▼ -1.4 pp |
| 2019 | 96.6% | CN¥2.71 Billion | CN¥2.81 Billion | CN¥94.26 Million | ▲ +4.1 pp |
| 2018 | 92.6% | CN¥2.56 Billion | CN¥2.76 Billion | CN¥205.07 Million | ▼ -2.0 pp |
| 2017 | 94.5% | CN¥2.32 Billion | CN¥2.45 Billion | CN¥133.91 Million | ▼ -0.1 pp |
| 2016 | 94.6% | CN¥2.10 Billion | CN¥2.22 Billion | CN¥118.63 Million | ▼ -2.2 pp |
| 2015 | 96.8% | CN¥1.88 Billion | CN¥1.94 Billion | CN¥62.00 Million | ▲ +6.8 pp |
| 2014 | 90.0% | CN¥646.64 Million | CN¥718.35 Million | CN¥71.71 Million | ▼ -1.2 pp |
| 2013 | 91.3% | CN¥493.71 Million | CN¥541.04 Million | CN¥47.33 Million | ▲ +0.2 pp |
| 2012 | 91.1% | CN¥359.96 Million | CN¥395.13 Million | CN¥35.18 Million | ▲ +2.7 pp |
| 2011 | 88.4% | CN¥247.37 Million | CN¥279.77 Million | CN¥32.39 Million | — |